Magnus Life Science Sets Up Five R&D-Centric Units At Top U.K. University
This article was originally published in The Pink Sheet Daily
Executive Summary
The unique industrial collaboration with University College London will exploit in-depth knowledge of blood-flow biology to develop new products for CV disease, fetal growth retardation and melanoma.